A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61P 3/10 (2006.01) C07K 16/28 (2006.01) C07K 16/32 (2006.01)
Patent
CA 2671585
The present invention relates to the use of at least one epidermal growth factor receptor specific antibody or a derivative thereof for the manufacture of a medicament for the treatment of diabetes, in particular of the advanced insulin-dependent stage of diabetes mellitus Type 1 and 2 in humans as well as in animals.
L'invention concerne l'utilisation d'au moins un anticorps spécifique du récepteur du facteur de croissance épidermique ou un dérivé de ce dernier dans la fabrication d'un médicament destiné au traitement du diabète, en particulier du stade avancé, dépendant de l'insuline, du diabète sucré de type 1 et de type 2 chez les humains et chez les animaux.
Kornek Gabriela
Selzer Edgar
Benoit & Cote,s.e.n.c.
Novelix Therapeutics Gmbh
LandOfFree
Treatment of diabetes by at least one epidermal growth... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of diabetes by at least one epidermal growth..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of diabetes by at least one epidermal growth... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1576919